Analysts on Wall Street project that Bally's (BALY) will announce quarterly loss of -$0.71 per share in its forthcoming report, representing an increase of 64.3% year over year. Revenues are projected to reach $659.65 million, increasing 4.7% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings anno ...

Core Insights - American Healthcare REIT (AHR) is expected to report quarterly earnings of $0.42 per share, reflecting a year-over-year increase of 16.7% [1] - Projected revenues for AHR are anticipated to be $565.26 million, which represents a 7.9% increase from the same quarter last year [1] - The consensus EPS estimate has remained stable over the last 30 days, indicating a collective reevaluation by analysts [1] Revenue Estimates - Analysts predict 'Revenues- Resident fees and services' to be $535.68 million, showing a year-over-year increase of 12.3% [4] - The consensus estimate for 'Revenues- Real estate revenue' is $39.47 million, indicating a decline of 16% from the prior-year quarter [4] Other Financial Metrics - 'Depreciation and amortization' is forecasted to reach $42.39 million [5] - AHR shares have increased by 12% over the past month, outperforming the Zacks S&P 500 composite, which saw a 1% increase [5] - AHR holds a Zacks Rank 2 (Buy), suggesting it is expected to outperform the overall market in the near future [5]

Analysts on Wall Street project that Enterprise Products Partners (EPD) will announce quarterly earnings of $0.67 per share in its forthcoming report, representing an increase of 3.1% year over year. Revenues are projected to reach $12.59 billion, declining 8.6% from the same quarter last year.The consensus EPS estimate for the quarter has undergone a downward revision of 1.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their ...

Core Viewpoint - Analysts project Novartis (NVS) will report quarterly earnings of $2.26 per share, reflecting a 9.7% year-over-year increase, with revenues expected to reach $13.9 billion, an 8.4% increase from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [1][2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [2]. Revenue Projections - Analysts expect 'Revenues- Oncology- Tafinlar + Mekinist- Total' to be $555.75 million, a 4.1% increase year-over-year [4]. - 'Revenues- Net sales to third parties' are projected to reach $14.07 billion, indicating a 9.8% year-over-year change [4]. - 'Revenues- Oncology- Kisqali- Total' is estimated at $1.29 billion, reflecting a significant 64.2% year-over-year increase [4]. Specific Revenue Metrics - 'Revenues- Immunology- Cosentyx- Total' is expected to reach $1.72 billion, a 1.9% increase from the prior year [5]. - 'Revenues- Oncology- Tasigna- US' is projected at $119.43 million, showing a decline of 47.2% year-over-year [5]. - 'Revenues- Oncology- Promacta/Revolade- US' is estimated at $180.08 million, indicating a 41.2% decrease from the year-ago quarter [5]. Additional Revenue Insights - 'Revenues- Immunology- Cosentyx- US' is expected to be $990.42 million, a slight decrease of 0.3% year-over-year [6]. - 'Revenues- Cardiovascular- Entresto- US' is projected at $927.94 million, reflecting a 1.8% increase from the previous year [6]. - 'Revenues- Oncology- Tasigna- ROW' is estimated at $149.03 million, indicating a 22.8% decline year-over-year [7]. - 'Revenues- Oncology- Tafinlar + Mekinist- ROW' is expected to reach $320.55 million, a 4.4% increase year-over-year [7]. - 'Revenues- Oncology- Promacta/Revolade- ROW' is projected at $267.72 million, reflecting a 1.8% increase [7]. - 'Revenues- Immunology- Cosentyx- ROW' is expected to be $734.58 million, indicating a 4.9% increase from the prior year [8]. Stock Performance - Novartis shares have increased by 6.9% over the past month, outperforming the Zacks S&P 500 composite, which saw a 0.2% increase [8].

Core Viewpoint - Nutrien (NTR) is expected to report quarterly earnings of $2.40 per share, a 2.6% increase year-over-year, with revenues projected at $10.61 billion, reflecting a 4.5% year-over-year growth [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 14.2%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Sales- Retail (Nutrient Ag Solutions)- Total' to reach $8.40 billion, a year-over-year increase of 4.1% [5]. - The consensus estimate for 'Sales- Nitrogen' is $1.25 billion, indicating a 4.9% increase from the previous year [5]. - 'Sales- Potash' is estimated at $892.38 million, reflecting a 6.7% year-over-year change [5]. - 'Sales- Phosphate' is expected to be $436.29 million, showing a decline of 3.3% from the prior year [6]. Sales Volumes - 'Potash - Sales volumes - Total' is projected at 3,613 thousand tons, up from 3,563 thousand tons year-over-year [6]. - 'Nitrogen - Sales volumes - Total' is expected to reach 2,947 thousand tons, compared to 2,818 thousand tons in the same quarter last year [7]. - 'Phosphate - Sales volumes - Total' is forecasted at 575 thousand tons, down from 584 thousand tons year-over-year [8]. - 'Potash - Sales volumes - North America' is estimated at 1,004 thousand tons, compared to 914 thousand tons in the same quarter last year [9]. - 'Nitrogen - Sales volumes - Ammonia' is projected to be 738 thousand tons, up from 698 thousand tons year-over-year [10]. Price Projections - The average selling price per tonne for 'Phosphate - Industrial and feed' is expected to be $755, down from $830 year-over-year [7]. - The average selling price per tonne for 'Phosphate - Total' is projected at $651, compared to $667 in the previous year [8]. Stock Performance - Nutrien shares have decreased by 1.4% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.3% [11].

Core Viewpoint - The upcoming earnings report from Automatic Data Processing (ADP) is anticipated to show a quarterly earnings per share (EPS) of $2.22, reflecting a 6.2% increase year-over-year, with revenues expected to reach $5.05 billion, indicating a 5.9% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised down by 0.1% over the last 30 days, indicating a collective reevaluation by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts project 'Revenues- Interest on funds held for clients' to be $286.31 million, a 3.4% increase from the year-ago quarter [5]. - The consensus estimate for 'Revenues- PEO revenues' is $1.63 billion, suggesting a 5.2% year-over-year change [5]. - 'Revenues- Revenues, other than interest on funds held for clients and PEO revenues' is expected to reach $3.13 billion, indicating a 6.3% increase year-over-year [6]. - The average prediction for 'Segment revenues- Employer Services' is $3.43 billion, reflecting a 6.4% change from the previous year [6]. - 'Segment revenues- PEO Services' is projected to be $1.63 billion, a 5% increase from the year-ago quarter [7]. Employee Metrics - Analysts estimate that the 'Average paid PEO worksite employees during the period' will reach 757, compared to 742 in the previous year [7]. Market Performance - ADP shares have shown a return of +1.1% over the past month, while the Zacks S&P 500 composite has increased by +4.6% [7].

Core Insights - CoStar Group (CSGP) is expected to report quarterly earnings of $0.14 per share, a decline of 6.7% year-over-year, with revenues forecasted at $771.67 million, reflecting a 13.8% increase compared to the same period last year [1] Earnings Estimates - The consensus EPS estimate for the quarter has not changed over the past 30 days, indicating that analysts have maintained their initial projections [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3] Revenue Projections - The consensus estimate for CoStar's total revenues is $267.89 million, indicating a year-over-year change of +5.9% [5] - Analysts project 'Revenues- Information Services' to reach $36.74 million, reflecting a +10% change from the prior-year quarter [5] - 'Revenues- Other Marketplaces' are expected to be $50.20 million, showing a significant increase of +60.9% year-over-year [5] - 'Revenues- LoopNet' is forecasted at $74.65 million, indicating a +6.9% change [6] - 'Revenues- Residential' is expected to be $31.02 million, reflecting an +18.4% increase [6] - The average prediction for 'Revenues- Multifamily' stands at $293.26 million, indicating an +11% change from the prior-year quarter [6] Stock Performance - CoStar shares have increased by +7% in the past month, outperforming the Zacks S&P 500 composite, which has risen by +4.2% [6] - CoStar holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]

Core Insights - Ooma (OOMA) is expected to report quarterly earnings of $0.18 per share, reflecting a 28.6% increase year-over-year [1] - Analysts forecast revenues of $64.82 million, indicating a 3.7% year-over-year growth [1] - The consensus EPS estimate has remained unchanged over the last 30 days, suggesting stability in analyst projections [1] Revenue Projections - Analysts estimate 'Revenue- Product and other' to reach $4.56 million, representing an 11.1% increase from the previous year [4] - 'Revenue- Subscription and services' is projected to be $60.92 million, showing a year-over-year change of 4.3% [4] Gross Margin Insights - The consensus for 'Gross Margin- Subscription and services' is expected to be 70.7%, an improvement from the year-ago figure of 70% [4] Stock Performance - Ooma shares have increased by 8.7% in the past month, outperforming the Zacks S&P 500 composite's 8.2% increase [5] - Ooma holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [5]

Core Insights - American Public Education (APEI) is expected to report quarterly earnings of $0.15 per share, a significant increase of 350% year-over-year [1] - Forecasted revenues for APEI are $161.94 million, reflecting a year-over-year increase of 4.9% [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' projections [1] Revenue Projections - Revenues for Rasmussen University (RU) are projected to be $57.19 million, representing a year-over-year increase of 7.6% [4] - Revenues for Hondros College, Nursing Programs (HCN) are estimated at $18.07 million, indicating a year-over-year increase of 9.9% [4] - Revenues for American Military & Public University (APUS) are forecasted to reach $82.42 million, reflecting a year-over-year change of 2.2% [5] Market Performance - APEI shares have increased by 5.6% over the past month, compared to a 11.3% increase in the Zacks S&P 500 composite [6] - APEI holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6]

Core Viewpoint - Tradeweb Markets (TW) is expected to report quarterly earnings of $0.85 per share, reflecting a 19.7% increase year-over-year, with revenues projected at $507.07 million, a 24.1% increase compared to the previous year [1]. Earnings Projections - Over the last 30 days, the consensus EPS estimate for the quarter has been revised upward by 2.5%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts project 'Revenue by Asset Class- Total Variable' to be $378.73 million, marking a 26.6% increase from the year-ago quarter [5]. - The estimate for 'Revenue by Asset Class- Other' is $6.33 million, indicating a year-over-year change of 6.6% [5]. - 'Revenue by Asset Class- Rates- Variable' is expected to reach $194.92 million, reflecting a 26.8% increase from the previous year [5]. - 'Revenue by Asset Class- Rates- Fixed' is estimated at $65.86 million, showing a 9.1% increase year-over-year [6]. Volume Metrics - The average daily volumes for 'Rates - Cash' are projected at $554.53 billion, up from $461.83 billion a year ago [6]. - Total average daily volumes are expected to reach $2,501.84 billion, compared to $1,899.64 billion in the same quarter last year [7]. - 'Average Daily Volumes - Money Markets' is estimated at $997.13 billion, significantly higher than the $576.57 billion reported in the same quarter last year [7]. - 'Average Daily Volumes - Equities' is projected at $28.62 billion, compared to $27.45 billion in the previous year [8]. - 'Average Daily Volumes - Credit' is expected to reach $42.25 billion, up from $34.92 billion a year ago [8]. - 'Average Daily Volumes - Rates' is estimated at $1,434.26 billion, compared to $1,260.7 billion in the same quarter last year [9]. Fee Estimates - Analysts predict 'Average variable fees per million dollars of volume - Equities' to be $16.72, up from $14.68 a year ago [9]. - 'Average variable fees per million dollars of volume - Credit' is expected to reach $45.46, down from $50.39 in the previous year [10]. Stock Performance - Over the past month, Tradeweb shares have recorded a return of -8.1%, compared to a -0.8% change in the Zacks S&P 500 composite [10].